Assessing Patient Risk, Benefit, and Outcomes in Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer Indications
Titel:
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer Indications
Auteur:
Hunter Hall, Rafe Wright, Carson L. Hughes, Griffin K. Peña, Andriana M. Ladd, Chase Gardner, Brooke McIntire, Ryan Ferrell, Matt Rubenstein, Jane Tuia, Jordan Haslam, Alyson Prasad, Vinay Vassar, Matt